Pesta 2012 Abstract Bioblast: Difference between revisions
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
|title=Pesta D (2012) The effect of targeted knockdown of the ''Indy'' gene on energy metabolism in rats. Mitochondr Physiol Network 17.12. | |title=Pesta D (2012) The effect of targeted knockdown of the ''Indy'' gene on energy metabolism in rats. Mitochondr Physiol Network 17.12. | ||
|info=[[MiPNet17.12 Bioblast 2012|MiPNet17.12 Bioblast 2012 - Open Access]] | |info=[[MiPNet17.12 Bioblast 2012|MiPNet17.12 Bioblast 2012 - Open Access]] | ||
|authors=Pesta D | |authors=Pesta D, Jamison Perry R, Zhang D, Jurczak M, Samuel V, Shulman GI | ||
|year=2012 | |year=2012 | ||
|event=[[Bioblast 2012]] | |event=[[Bioblast 2012]] | ||
|abstract=INDY as part of the SLC13 protein family is a high-affinity di- and tricarboxylate plasma membrane transporter involved in citrate import. Besides the effect on longevity, our lab has shown that deletion of INDY repatterns energy metabolism in a way that protects mice form high fat diet induced insulin resistance 1. In the present work, we use anti-sense oligonucleotides (ASOs) to study the effects of a constitutional knock down of the mitochondrial Indy protein (mINDY) in the liver of rats on energy and glucose metabolism assessed by a hyperinsulinemic euglycemic clamp (HEC). Rats were fed a high fat diet (safflower diet) for 4 weeks. The treatment group (n=12) was injected 2 times per week with Indy ASO, the control group (n=12) with the same volume of saline. After 4 weeks of treatment, mINDY mRNA was reduced by 84% (p<0.05) in the treatment group. Hepatic triglycerides were reduced by 17% in mINDY ASO treated rats (52.1 vs. 43.1 mg/g liver, p=0.02). Basal (6.8 vs 8.6 mg/kg/min, p=0.19) as well as insulin stimulated glucose turnover (29.4 vs 35.2 mg/kg/min, p=0.07) and suppression of hepatic glucose production during HEC (32.2 vs 59.0%, p=0.14) trended higher in the mINDY ASO treated group. Peripheral glucose uptake was not different in muscle, but there was a trend of increased uptake in WAT (21.2 vs 52.3 nmol/g/min, p=0.12). | |||
These preliminary data suggest increased insulin sensitivity in mINDY ASO treated rats, possibly by shifting intracellular lipid storage from liver and muscle, where their accumulation impairs insulin signaling, to WAT. | |||
|keywords=Indy, ASO, citrate, mitochondria | |||
|journal=Mitochondr Physiol Network | |journal=Mitochondr Physiol Network | ||
|articletype=Abstract | |articletype=Abstract |
Revision as of 17:48, 23 October 2012
Pesta D (2012) The effect of targeted knockdown of the Indy gene on energy metabolism in rats. Mitochondr Physiol Network 17.12. |
Link: MiPNet17.12 Bioblast 2012 - Open Access
Pesta D, Jamison Perry R, Zhang D, Jurczak M, Samuel V, Shulman GI (2012)
Event: Bioblast 2012
INDY as part of the SLC13 protein family is a high-affinity di- and tricarboxylate plasma membrane transporter involved in citrate import. Besides the effect on longevity, our lab has shown that deletion of INDY repatterns energy metabolism in a way that protects mice form high fat diet induced insulin resistance 1. In the present work, we use anti-sense oligonucleotides (ASOs) to study the effects of a constitutional knock down of the mitochondrial Indy protein (mINDY) in the liver of rats on energy and glucose metabolism assessed by a hyperinsulinemic euglycemic clamp (HEC). Rats were fed a high fat diet (safflower diet) for 4 weeks. The treatment group (n=12) was injected 2 times per week with Indy ASO, the control group (n=12) with the same volume of saline. After 4 weeks of treatment, mINDY mRNA was reduced by 84% (p<0.05) in the treatment group. Hepatic triglycerides were reduced by 17% in mINDY ASO treated rats (52.1 vs. 43.1 mg/g liver, p=0.02). Basal (6.8 vs 8.6 mg/kg/min, p=0.19) as well as insulin stimulated glucose turnover (29.4 vs 35.2 mg/kg/min, p=0.07) and suppression of hepatic glucose production during HEC (32.2 vs 59.0%, p=0.14) trended higher in the mINDY ASO treated group. Peripheral glucose uptake was not different in muscle, but there was a trend of increased uptake in WAT (21.2 vs 52.3 nmol/g/min, p=0.12). These preliminary data suggest increased insulin sensitivity in mINDY ASO treated rats, possibly by shifting intracellular lipid storage from liver and muscle, where their accumulation impairs insulin signaling, to WAT.
• Keywords: Indy, ASO, citrate, mitochondria
Labels: